118 related articles for article (PubMed ID: 1689705)
1. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
[TBL] [Abstract][Full Text] [Related]
2. Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.
Dillner J
Int J Cancer; 1990 Oct; 46(4):703-11. PubMed ID: 1698732
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
Cason J; Kambo PK; Best JM; McCance DJ
Int J Cancer; 1992 Feb; 50(3):349-55. PubMed ID: 1310487
[TBL] [Abstract][Full Text] [Related]
4. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
5. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
[TBL] [Abstract][Full Text] [Related]
6. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
[TBL] [Abstract][Full Text] [Related]
7. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.
Jenison SA; Yu XP; Valentine JM; Galloway DA
J Virol; 1989 Feb; 63(2):809-18. PubMed ID: 2463384
[TBL] [Abstract][Full Text] [Related]
8. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
[TBL] [Abstract][Full Text] [Related]
10. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
11. Binding by immunoglobulin to the HPV-16-derived proteins L1 and E4 in cervical secretions of women with HPV-related cervical disease.
Snyder KA; Barber SR; Symbula M; Taylor PT; Crum CP; Roche JK
Cancer Res; 1991 Aug; 51(16):4423-9. PubMed ID: 1651158
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides.
Suchánková A; Krchnák V; Vágner J; Hamsíková E; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1992 Feb; 73 ( Pt 2)():429-32. PubMed ID: 1371544
[TBL] [Abstract][Full Text] [Related]
13. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
14. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
16. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
17. Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2.
Volpers C; Sapp M; Snijders PJ; Walboomers JM; Streeck RE
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2661-7. PubMed ID: 7595373
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups.
Heim K; Christensen ND; Hoepfl R; Wartusch B; Pinzger G; Zeimet A; Baumgartner P; Kreider JW; Dapunt O
J Infect Dis; 1995 Aug; 172(2):395-402. PubMed ID: 7542685
[TBL] [Abstract][Full Text] [Related]
19. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.
van Doornum G; Prins M; Andersson-Ellström A; Dillner J
Sex Transm Infect; 1998 Oct; 74(5):354-60. PubMed ID: 10195032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]